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Cronobacter Sakazakii Bacteremia in a 76-year-old Woman: A Case 
Report 
 
Amy Kang,1 Nancy Garcia,2 Bhanu Sud2 & Lee Nguyen3 
 
Abstract 
 
 
Cronobacter sakazakii, commonly found in contaminated infant formula and thereby 
causes infantile bacteremia, is rarely associated with adult bacteremia. We present the 
tenth case of C. sakazakii bacteremia in adults. The patient is a 76-year-old woman 
who resides in a skilled nursing facility and presents with risk factors including 
bullous pemphigoid, Type II diabetes mellitus, hypertension, hyperlipidemia, chronic 
kidney disease, and anemia. The therapy was started with intravenous ciprofloxacin 
and vancomycinempirically. After consultation with an Infectious Diseases specialist, 
ciprofloxacin and vancomycin was replaced with meropenem based on the patient’s 
extensive bullous lesions, history of ESBL infections, and possible pneumonia.  
Later, the therapy was de-escalated to intravenous ceftriaxone and vancomycin after 
culture and sensitivity testing were available and clinical signs of improvements were 
evident. She was sent back to her skilled nursing but was re-admitted 10-days later.  
She was placed on dialysis for altered mental status secondary to acute renal failure.  
Blood and urine cultures were repeated and had no evidence of bacterial growth.  
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1. Introduction 
 
Cronobacter (Enterobacter) sakazakii related infections are infrequently seen 
in adults, but can be serious among people with immunocompromising conditions 
and the elderly.  Only nine cases of bacteremia have been previously published in the 
medical literature (Emery & Weymouth, 1997; Hawkins, Lissner, & Sanford, 1991; 
Jimenez & Gimenez, 1982; Lai 2001; Pribyl et al., 1985; See, Than, & Tang, 2007). 
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We present a case of C. sakazakii bacteremia in a 76-year-old female who was 
brought to the emergency department in December 2013 from a skilled nursing 
facility (SNF) with increased confusion, left abdominal pain, and reports of fever per 
family member. This patient had various co-morbid conditions including bullous 
pemphigoid, Type II diabetes mellitus, hypertension, hyperlipidemia, chronic kidney 
disease, anemia, and a history of Clostridium difficile and extended-spectrum beta-
lactamase (ESBL) Enterobacteriaceae urinary tract infections, and uterine cancer with 
a vague history of penicillin and sulfa allergies. Of note, she has been receiving 
chronic steroid therapy for bullous pemphigoid and finishing a tapering dose of oral 
vancomycin. At presentation, she had confusion, left upper quadrant abdominal 
tenderness and guarding, right-sided rhonchi, and 2+ edema with notable oozing 
from her lower extremities without other significant findings. Laboratory results 
revealed normal leukocyte (10.3/mm3) and lowered platelet counts (82,000/mm3), but 
had elevated band neutrophils (36%), elevated potassium (5.2-mEq/L), blood urine 
nitrogen (105-mg/dL), creatinine (2-mg/dL), and procalcitonin (0.16-ng/mL). 
Urinalysis was positive for nitrites, leukocyte esterase (3+), protein (1+), and white 
blood cells (18/mm3). The chest radiograph showed a new infiltrate on the right 
middle lung field. On admission, intravenous ciprofloxacin and vancomycin was 
started empirically considering the patient’s allergy profile. The following morning, 
the patient was seen by an Infectious Diseases specialist. The extensive bullous 
lesions, history of ESBL infections, and possible pneumonia prompted the 
replacement of ciprofloxacin with meropenem. 
 
Urine, nares, and two sets of blood cultures were obtained on admission. The 
urine culture had >105 colony-forming units of Proteus mirabilis, and the nares culture 
identified methicillin-resistant Staphylococcus aureuspresence. After one day of 
incubation, two of four blood culture bottles were positive for bacterial growth, C. 
sakazakii and diphtheroid group bacteria. The Cronobacter was susceptible to the 
following antibiotics: amikacin, cefepime, ceftazidime, ceftriaxone, ciprofloxacin, 
ertapenem, gentamicin, meropenem, piperacillin-tazobactam, tobramycin, and 
trimethoprim/sulfamethoxazole. The Cronobacter was resistant to cefazolin and 
cefoxitin. The open leg wounds and probable pneumoniawere the most probable 
sources of the bacteremia. The remaining chief complaint for left upper quadrant pain 
was evaluated for a gastric ulcer perforation and the computerized tomography (CT) 
scan of the abdomen and pelvis did not find evidence of an acute abnormalities.  
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After microbiology susceptibilities were available and a clinical response to 
antimicrobial therapy was evident, the patient was de-escalated to intravenous 
ceftriaxone and vancomycin. Therapy was changed to account for the 
fluoroquinolone-resistant, cephalosporin-sensitive Proteus mirabilis in the urine, and 
possible pneumonia. Repeat blood cultures were negative for any bacterial growth. 
After aggressive hydration, antibiotics, and intravenous steroids, the patient stabilized 
and improved.  She was sent back to her SNF to complete her antimicrobial therapy.  
The patient was re-admitted 10-days later for altered mental status secondary to acute 
renal failure and placed on dialysis.  Blood and urine cultures were repeated and had 
no evidence of bacterial growth. 
 
2. Discussion 
 
Previous reports of Cronobacter bacteremia resulted in mixed success.  Five 
of the nine previous cases resulted in patient mortality (Table 1). It has been suggested 
that empiric treatment of Cronobacter infections should be include either a 
carbapenem or a later generation cephalosporin (Dennison & Morris, 2002).  
Effective empiric therapy is important as well as de-escalation to appropriate directed 
therapy based on susceptibilities. This current case demonstrates the potential for 
clinical cure with a third generation cephalosporin, and reinforces common 
characteristics seen in Cronobacter bacteremia.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
4                                  International Journal of Medicine and Pharmacy, Vol. 3(1), June 2015  
 
 
Table 1: Cronobacter (Enterobacter) Sakazakii Bacteremias in Adults 
 
Age/Gender Co-morbid 
Condition(s) 
Treatment Outcome Reference 
76/ male Rectal adenocarcinoma Ampicillin + gentamicin Successful  Jimenez, 
1982 
55/ male Diabetes Aztreonam Successful Pribyl, 
1985 
75/ female Chronic atrial 
fibrillation, CVA, 
hypertension 
Cefuroxime; ceftriaxone; 
ciprofloxacin 
Successful Hawkins, 
1991 
68/ male CLL, alcohol abuse Ceftriaxone + gentamicin Died Emery, 
1997 
39/ male Tonsillar carcinoma Ceftazidime + clindamycin; 
cefuroxime axetil + clindamycin 
Successful Lai, 2001 
73/ female Klatskin tumor Piperacillin-tazobactam+ 
gentamicin; imipenem 
Died  Lai, 2001 
82/ female Abdominal aortic 
aneurysm 
Piperacillin-tazobactam + 
ofloxacin 
Died Lai, 2001 
76/ female Fungemia, cecal 
volvulus 
Ceftazidime + tobramycin; 
ofloxacin + tobramycin 
Died Lai, 2001 
75/ female Schizophrenia, splenic 
abscess 
Ceftriaxone +metronidazole; 
imipenem; ciprofloxacin  
Successful See, 2007 
 
Semicolons denotes division of initial and subsequent therapies 
CVA: Cerebrovascular Accident, CLL: Chronic Lymphocytic Leukemia 
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